Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy.
Journal: The Journal of allergy and clinical immunology
Published: July 28, 2022
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.
Journal: The journal of allergy and clinical immunology. In practice
Published: September 18, 2020
Optimal human pathogenic TH2 cell effector function requires local epithelial cytokine signaling.
Journal: The Journal of allergy and clinical immunology
Published: July 28, 2020
AR101 Oral Immunotherapy for Peanut Allergy.
Journal: The New England journal of medicine
Published: November 20, 2018
Oral Tolerance Development and Maintenance.
Journal: Immunology and allergy clinics of North America
Published: November 15, 2017
Ana o 1 and Ana o 2 cashew allergens share cross-reactive CD4(+) T cell epitopes with other tree nuts.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: October 17, 2015
A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders.
Journal: Science translational medicine
Published: May 15, 2015
Jug r 2-reactive CD4(+) T cells have a dominant immune role in walnut allergy.
Journal: The Journal of allergy and clinical immunology
Published: September 04, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026